These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 9234691

  • 1. p21CIP1 and Cdc25A: competition between an inhibitor and an activator of cyclin-dependent kinases.
    Saha P, Eichbaum Q, Silberman ED, Mayer BJ, Dutta A.
    Mol Cell Biol; 1997 Aug; 17(8):4338-45. PubMed ID: 9234691
    [Abstract] [Full Text] [Related]

  • 2. Reduction of Cdc25A contributes to cyclin E1-Cdk2 inhibition at senescence in human mammary epithelial cells.
    Sandhu C, Donovan J, Bhattacharya N, Stampfer M, Worland P, Slingerland J.
    Oncogene; 2000 Nov 09; 19(47):5314-23. PubMed ID: 11103932
    [Abstract] [Full Text] [Related]

  • 3. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
    Foster JS, Henley DC, Bukovsky A, Seth P, Wimalasena J.
    Mol Cell Biol; 2001 Feb 09; 21(3):794-810. PubMed ID: 11154267
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D.
    Oncogene; 1999 May 06; 18(18):2798-810. PubMed ID: 10362250
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J, Ammanamanchi S, Ko TC, Brattain MG.
    Cancer Res; 2003 Jun 15; 63(12):3340-6. PubMed ID: 12810668
    [Abstract] [Full Text] [Related]

  • 8. A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2.
    Sexl V, Diehl JA, Sherr CJ, Ashmun R, Beach D, Roussel MF.
    Oncogene; 1999 Jan 21; 18(3):573-82. PubMed ID: 9989807
    [Abstract] [Full Text] [Related]

  • 9. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.
    Orend G, Hunter T, Ruoslahti E.
    Oncogene; 1998 May 21; 16(20):2575-83. PubMed ID: 9632134
    [Abstract] [Full Text] [Related]

  • 10. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition.
    Hoffmann I, Draetta G, Karsenti E.
    EMBO J; 1994 Sep 15; 13(18):4302-10. PubMed ID: 7523110
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL, Buffolino P, Kopman C, Nathanson L.
    Exp Cell Res; 1995 Nov 15; 221(1):92-102. PubMed ID: 7589260
    [Abstract] [Full Text] [Related]

  • 12. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T, Yoshida T, Tsujita T, Shimizu M, Mizukami T, Okabe M, Akinaga S.
    Cancer Res; 1997 Apr 15; 57(8):1495-501. PubMed ID: 9108451
    [Abstract] [Full Text] [Related]

  • 13. The p21(Cip1) protein, a cyclin inhibitor, regulates the levels and the intracellular localization of CDC25A in mice regenerating livers.
    Jaime M, Pujol MJ, Serratosa J, Pantoja C, Canela N, Casanovas O, Serrano M, Agell N, Bachs O.
    Hepatology; 2002 May 15; 35(5):1063-71. PubMed ID: 11981756
    [Abstract] [Full Text] [Related]

  • 14. Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc.
    Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B.
    EMBO J; 1996 Dec 02; 15(23):6595-604. PubMed ID: 8978686
    [Abstract] [Full Text] [Related]

  • 15. Bovine papillomavirus E2 protein activates a complex growth-inhibitory program in p53-negative HT-3 cervical carcinoma cells that includes repression of cyclin A and cdc25A phosphatase genes and accumulation of hypophosphorylated retinoblastoma protein.
    Naeger LK, Goodwin EC, Hwang ES, DeFilippis RA, Zhang H, DiMaio D.
    Cell Growth Differ; 1999 Jun 02; 10(6):413-22. PubMed ID: 10392903
    [Abstract] [Full Text] [Related]

  • 16. A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.
    Coats S, Whyte P, Fero ML, Lacy S, Chung G, Randel E, Firpo E, Roberts JM.
    Curr Biol; 1999 Feb 25; 9(4):163-73. PubMed ID: 10074425
    [Abstract] [Full Text] [Related]

  • 17. Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity.
    Guadagno TM, Newport JW.
    Cell; 1996 Jan 12; 84(1):73-82. PubMed ID: 8548828
    [Abstract] [Full Text] [Related]

  • 18. p21 contains independent binding sites for cyclin and cdk2: both sites are required to inhibit cdk2 kinase activity.
    Fotedar R, Fitzgerald P, Rousselle T, Cannella D, Dorée M, Messier H, Fotedar A.
    Oncogene; 1996 May 16; 12(10):2155-64. PubMed ID: 8668341
    [Abstract] [Full Text] [Related]

  • 19. Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.
    Prall OW, Sarcevic B, Musgrove EA, Watts CK, Sutherland RL.
    J Biol Chem; 1997 Apr 18; 272(16):10882-94. PubMed ID: 9099745
    [Abstract] [Full Text] [Related]

  • 20. Cell cycle exit during terminal erythroid differentiation is associated with accumulation of p27(Kip1) and inactivation of cdk2 kinase.
    Hsieh FF, Barnett LA, Green WF, Freedman K, Matushansky I, Skoultchi AI, Kelley LL.
    Blood; 2000 Oct 15; 96(8):2746-54. PubMed ID: 11023508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.